Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Biomunex Appoints Dr. Simon Plyte, PhD, as Chief Scientific Officer
Biomunex Pharmaceuticals, a biopharmaceutical company that develops cutting-edge immunotherapies through the discovery and development of […]
CHMP Recommends EU Approval of Roche’s Tecentriq as Adjuvant Treatment for a Subset of People with Early-stage Non-small Cell Lung Cancer
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Medicines Agency’s (EMA) Committee […]
Epitopea Announces $14 Million Financing to Advance Cancer Immunotherapeutics
Epitopea, a transatlantic cancer immunotherapeutics company and global leader in exploiting a new class of […]
MitoRx Therapeutics Announces Seed Financing to Advance its Mitochondrial-Protective Therapeutics to Treat Degenerative Diseases
MitoRx Therapeutics (MitoRx), a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction to arrest […]
Mobile Cataract Units and Same-day Hip Replacements Helping Thousands Get NHS Treatment
Same-day hip replacements, one stop shops and mobile cataract units are just some of the […]
Minnesota Neurosurgeon Among First in Country to Perform Navigated Spine Fusions With Inspired Spine OLLIF Technology | Pharmtech Focus
Dr. Uzma Samadani, A Minneapolis neurosurgeon renowned for spine tumor resection and complex neurotrauma repair has completed 4 […]
GSK Reaches Agreement to Acquire Late-stage Biopharmaceutical Company Sierra Oncology for $1.9bn
GlaxoSmithKline plc (LSE/NYSE: GSK) and Sierra Oncology, Inc (Nasdaq: SRRA) today announced that the companies […]
Cannabotech's Botanical Drug for Pancreatic Cancer Has Demonstrated Killing 100% of Cancer Cells Without Damaging the Healthy Cells in the Cell Model
Cannabotech (CNTC.TA), which is involved in the development of a botanical drug based on an extract […]
Syndrome Post-COVID: First Results of the Collaboration Between Fondamental & GeNeuro
GeNeuro (Euronext Paris: CH0308403085 – GNRO), a biopharmaceutical company developing new treatments for neurodegenerative and autoimmune […]
Major Journal Publishes Landmark Proteomics Study Demonstrating Development of an Unprecedented New Clinical Cardiovascular Risk Test
In one of the largest proteomic studies ever conducted and published April 6 in the […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more